Laura M. Shelton, Ph.D. - Publications

Area:
metabolic therapy

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2018 Flores RE, Brown AK, Taus L, Khoury J, Glover F, Kami K, Sarangarajan R, Walshe T, Narain NR, Kiebish MA, Shelton L, Chinopoulos C, Seyfried TN. Mycoplasma infection and hypoxia initiate succinate accumulation and release in the VM-M3 cancer cells. Biochimica Et Biophysica Acta. PMID 29580805 DOI: 10.1016/j.bbabio.2018.03.012  0.92
2016 Samanta D, Park Y, Andrabi SA, Shelton LM, Gilkes DM, Semenza GL. PHGDH Expression is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance and Lung Metastasis. Cancer Research. PMID 27280394 DOI: 10.1158/0008-5472.CAN-16-0530  0.92
2015 Kim D, Fiske BP, Birsoy K, Freinkman E, Kami K, Possemato RL, Chudnovsky Y, Pacold ME, Chen WW, Cantor JR, Shelton LM, Gui DY, Kwon M, Ramkissoon SH, Ligon KL, et al. SHMT2 drives glioma cell survival in ischaemia but imposes a dependence on glycine clearance. Nature. 520: 363-7. PMID 25855294 DOI: 10.1038/nature14363  0.92
2013 Smagghe BJ, Stewart AK, Carter MG, Shelton LM, Bernier KJ, Hartman EJ, Calhoun AK, Hatziioannou VM, Lillacci G, Kirk BA, DiNardo BA, Kosik KS, Bamdad C. MUC1* ligand, NM23-H1, is a novel growth factor that maintains human stem cells in a more naïve state. Plos One. 8: e58601. PMID 23505541 DOI: 10.1371/journal.pone.0058601  0.92
2013 Seyfried TN, Shelton LM, Huysentruyt LC. The VM mouse model of glioblastoma multiforme Neuromethods. 77: 39-55. DOI: 10.1007/7657_2012_34  0.92
2012 Shelton L, Pendse G, Maleki N, Moulton EA, Lebel A, Becerra L, Borsook D. Mapping pain activation and connectivity of the human habenula. Journal of Neurophysiology. 107: 2633-48. PMID 22323632 DOI: 10.1152/jn.00012.2012  0.92
2012 Shelton L, Becerra L, Borsook D. Unmasking the mysteries of the habenula in pain and analgesia Progress in Neurobiology. 96: 208-219. PMID 22270045 DOI: 10.1016/j.pneurobio.2012.01.004  0.92
2012 Seyfried TN, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Is the restricted ketogenic diet a viable alternative to the standard of care for managing malignant brain cancer? Epilepsy Research. 100: 310-26. PMID 21885251 DOI: 10.1016/j.eplepsyres.2011.06.017  0.92
2011 Seyfried TN, Kiebish MA, Marsh J, Shelton LM, Huysentruyt LC, Mukherjee P. Metabolic management of brain cancer. Biochimica Et Biophysica Acta. 1807: 577-94. PMID 20804725 DOI: 10.1016/j.bbabio.2010.08.009  0.92
2010 Shelton LM, Huysentruyt LC, Mukherjee P, Seyfried TN. Calorie restriction as an anti-invasive therapy for malignant brain cancer in the VM mouse. Asn Neuro. 2: e00038. PMID 20664705 DOI: 10.1042/AN20100002  0.92
2010 Seyfried TN, Shelton LM, Mukherjee P. Does the existing standard of care increase glioblastoma energy metabolism? The Lancet. Oncology. 11: 811-3. PMID 20634134 DOI: 10.1016/S1470-2045(10)70166-2  0.92
2010 Shelton LM, Huysentruyt LC, Seyfried TN. Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model. International Journal of Cancer. Journal International Du Cancer. 127: 2478-85. PMID 20473919 DOI: 10.1002/ijc.25431  0.92
2010 Seyfried TN, Shelton LM. Cancer as a metabolic disease. Nutrition & Metabolism. 7: 7. PMID 20181022 DOI: 10.1186/1743-7075-7-7  0.92
2010 Shelton LM, Mukherjee P, Huysentruyt LC, Urits I, Rosenberg JA, Seyfried TN. A novel pre-clinical in vivo mouse model for malignant brain tumor growth and invasion. Journal of Neuro-Oncology. 99: 165-76. PMID 20069342 DOI: 10.1007/s11060-010-0115-y  0.92
2010 Huysentruyt LC, Shelton LM, Seyfried TN. Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer. International Journal of Cancer. Journal International Du Cancer. 126: 65-72. PMID 19536778 DOI: 10.1002/ijc.24649  0.92
2008 Huysentruyt LC, Mukherjee P, Banerjee D, Shelton LM, Seyfried TN. Metastatic cancer cells with macrophage properties: evidence from a new murine tumor model. International Journal of Cancer. Journal International Du Cancer. 123: 73-84. PMID 18398829 DOI: 10.1002/ijc.23492  0.92
2008 Mukherjee P, Faber AC, Shelton LM, Baek RC, Chiles TC, Seyfried TN. Thematic review series: sphingolipids. Ganglioside GM3 suppresses the proangiogenic effects of vascular endothelial growth factor and ganglioside GD1a. Journal of Lipid Research. 49: 929-38. PMID 18287616 DOI: 10.1194/jlr.R800006-JLR200  0.92
Show low-probability matches.